Cardiorespiratory pathogenesis of sickle cell disease in a mouse model
Jun Ren1,2, Xiuqing Ding1,2, Marie Trudel3
1Department of Physiology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Scientific Reports
|August 19, 2017
Summary
Sickle cell disease causes cardiorespiratory problems in mice, with early-life and adult phases of dysfunction. This mouse model reveals distinct subgroups mimicking human sickle cell disease complications.
Area of Science:
- Cardiorespiratory pathophysiology
- Animal models of human disease
- Sickle cell disease research
Background:
- Cardiorespiratory impairments in sickle cell disease (SCD) are not well understood.
- Clinical studies have limitations in investigating SCD pathophysiology from birth to maturity.
- The SAD mouse model offers a platform to study SCD-related cardiorespiratory issues.
Purpose of the Study:
- To characterize cardiorespiratory pathophysiology in the SAD mouse model from birth to adulthood.
- To identify critical phases of respiratory dysfunction in SAD mice.
- To understand the mechanisms underlying cardiorespiratory complications in SCD.
Main Methods:
- Longitudinal characterization of cardiorespiratory function in SAD mice from birth to maturity.
- Assessment of respiratory patterns, lung histology, and response to hypoxia.
- Evaluation of exercise capacity and cardiac function in adult SAD mice.
Main Results:
- Two critical phases of respiratory dysfunction were identified: pre-weaning and adulthood.
- Early-life SAD mice exhibited apneas, anemia, and pulmonary congestion, with high mortality.
- Adult SAD mice showed tachypnea, restrictive lung disease, pulmonary hypertension, cardiac enlargement, and impaired exercise capacity and hypoxic response.
Conclusions:
- The SAD mouse model recapitulates key cardiorespiratory complications seen in human sickle cell disease.
- Distinct subgroups of SAD mice exhibit varying cardiorespiratory phenotypes.
- This model provides valuable insights into the developmental trajectory of cardiorespiratory impairments in SCD.


